The appointment of Krebs is viewed as a positive step for Se...
The appointment of Krebs is viewed as a positive step for Sensei, as it may further the company's capabilities in strategic alliances, pipeline expansion and program development. Her extensive experience could be valuable to the company's growth.
Press Release: Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment